FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
9.88
+0.63 (6.81%)
At close: Aug 13, 2025, 4:00 PM
9.87
-0.01 (-0.10%)
Pre-market: Aug 14, 2025, 8:43 AM EDT
FibroGen Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for FibroGen stock ranges from a low of $43 to a high of $250. The average analyst price target of $146.5 forecasts a 1,382.79% increase in the stock price over the next year.
Price Target: $146.50 (+1,382.79%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FibroGen stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $43 | Strong Buy | Maintains | $10 → $43 | +335.22% | Aug 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $250 | Strong Buy | Reiterates | $250 | +2,430.36% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $250 | Strong Buy | Reiterates | $250 | +2,430.36% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $250 | Strong Buy | Reiterates | $250 | +2,430.36% | Feb 20, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $100 → $50 | Hold → Sell | Downgrades | $100 → $50 | +406.07% | Aug 8, 2023 |
Financial Forecast
Revenue This Year
10.19M
from 29.62M
Decreased by -65.62%
Revenue Next Year
9.81M
from 10.19M
Decreased by -3.66%
EPS This Year
-12.37
from -11.89
EPS Next Year
-18.49
from -12.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 13.3M | 13.9M | 14.4M | |
| Avg | 10.2M | 9.8M | 10.1M | |
| Low | 7.1M | 5.9M | 5.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -55.0% | 36.1% | 46.6% | |
| Avg | -65.6% | -3.7% | 2.6% | |
| Low | -75.9% | -41.9% | -39.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -3.68 | -15.23 | -14.44 | |
| Avg | -12.37 | -18.49 | -16.32 | |
| Low | -20.34 | -21.32 | -17.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.